Evidence map›Paper›PMID 42825118›Full record

ArticleACS omega2026

Quercetin Alleviates Ferroptosis-Induced Renal Fibrosis by Modulating the PRDM9/HMOX1/PTGS2 Axis.

Qiongqiong Zhu, Zhibin Chen, Xianxian Yu, Qiu Ye, Xu Chen

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiongqiong ZhuDepartment of Nephrology, Yueqing Hospital of Wenzhou Medical University, Wenzhou 325600, Zhejiang, Peoples R China.
Zhibin ChenDepartment of Nephrology, Yueqing Hospital of Wenzhou Medical University, Wenzhou 325600, Zhejiang, Peoples R China.
Xianxian YuDepartment of Nephrology, Yueqing Hospital of Wenzhou Medical University, Wenzhou 325600, Zhejiang, Peoples R China.
Qiu YeDepartment of Pharmacy, Yueqing Hospital of Wenzhou Medical University, Wenzhou 325600, Zhejiang, Peoples R China.
Xu ChenDepartment of Pharmacy, Yueqing Hospital of Wenzhou Medical University, Wenzhou 325600, Zhejiang, Peoples R China.ORCID https://orcid.org/0009-0006-9597-7253

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis-induced renal fibrosis is a key driver of chronic kidney disease (CKD) progression, yet effective therapies remain limited. This study investigates the therapeutic potential of quercetin (QCT), a bioflavonoid derived from

Identifiers

PMID42825118
PMCPMC13629372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.